Johnson & Johnson making the biggest investment in professional health journal advertising in 2014

Johnson & Johnson, the top pharma company advertising in professional health journals, more than doubles the second ranked company by dollars invested in advertising through August, according to Kantar Media. Johnson & Johnson makes up 7% of the total advertising share, but the company has decreased its spend by 6% year-over-year. Comparatively, GlaxoSmithKline is spending almost $11 million and has nearly doubled its spend since 2013.

Top 5 Print Ad Pharma Companies (Dollars): August 2014

  1. Johnson & Johnson – $25 MM (-6%)
  2. GlaxoSmithKline – $11 MM (+99%)
  3. Pfizer– $10 MM (-4%)
  4. Takeda – $9 MM (+1,282%)
  5. Novartis - $8 MM (+11%)

The percentage changes compare August 2014 to that same time period in 2013. For more information on these ad insights or other data, let one of us know.

Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.




Search article